Georgetown University

This study aimed to see if a medication called daratumumab could improve nerve damage symptoms in adults with MGUS, a blood condition that can harm nerves. Participants would have received injections weekly for two months, then every other week for four more months, while doctors…

This study is testing whether a combination of three chemotherapy drugs can help control advanced bile duct or gallbladder cancer that has worsened after initial treatment. It will involve about 48 adults whose cancer progressed despite standard chemotherapy. The main goal is to …

This study is testing whether a 6-month home-based walking program can improve metabolic health markers like blood sugar and cholesterol in people with and without HIV. Participants will gradually increase their daily steps to about 10,000, tracked with an activity monitor. The g…

This study is testing whether telephone counseling from a trained peer coach can help young women with a strong family history of breast cancer. The program aims to reduce stress, help with decision-making about genetic testing, and provide emotional support. It compares this pee…

This study is testing whether adding a drug called cabozantinib to two existing immunotherapy drugs (nivolumab and ipilimumab) can better control advanced melanoma that cannot be removed by surgery. The main goal is to see if this combination helps patients live longer without th…

This study is testing whether adding a new drug called tiragolumab to two existing cancer drugs (atezolizumab and bevacizumab) can help control advanced non-squamous lung cancer that has worsened after prior treatment. It will enroll about 29 adults whose cancer has specific gene…

This study is testing whether combining two drugs, BXCL701 and pembrolizumab, can help control metastatic pancreatic cancer that has worsened after initial treatment. It will measure if patients' cancer stays stable or shrinks for at least 18 weeks. The trial is for adults with a…

This study is testing a combination of two drugs, venetoclax and rituximab, for adults with chronic lymphocytic leukemia (CLL) that has returned or stopped responding to other treatments. The goal is to see how well and how safely this drug pair can control the cancer. Researcher…

This study is testing whether a 6-month video game training program can help people with Rett syndrome improve their ability to use their arms purposefully. Participants play specially designed games that require them to separate their hands and reach for targets, aiming to reduc…

This study is testing a new, easier way to help family members of people with a BRCA gene mutation learn about genetic testing. It compares a web-based education program followed by a short phone call to the usual way information is shared. The goal is to see if this approach hel…